Inovio Pharmaceuticals
INO
#8327
Rank
HK$2.39 B
Marketcap
HK$12.79
Share price
16.43%
Change (1 day)
-16.92%
Change (1 year)

EPS for Inovio Pharmaceuticals (INO)

EPS in 2026 (TTM): -HK$14.30

According to Inovio Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -HK$14.36. In 2025 the company made an earnings per share (EPS) of -HK$14.20 an increase over its 2024 EPS that were of -HK$30.99.

EPS history for Inovio Pharmaceuticals from 1999 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-HK$14.300.72%
2025-HK$14.20-54.18%
2024-HK$30.99-35.14%
2023-HK$47.78-56.62%
2022-HK$110.15-19.54%
2021-HK$136.9035.9%
2020-HK$100.74-11.57%
2019-HK$113.9215.24%
2018-HK$98.85-2.78%
2017-HK$101.686.93%
2016-HK$95.09134.88%
2015-HK$40.48-29.51%
2014-HK$57.43-57.34%
2013-HK$134.63146.55%
2012-HK$54.6020.83%
2011-HK$45.19-29.41%
2010-HK$64.02-48.48%
2009-HK$124.2710%
2008-HK$112.9711.11%
2007-HK$101.68-41.3%
2006-HK$173.23-66.91%
2005-HK$523.45110.61%
2004-HK$248.54-61.63%
2003-HK$647.72186.67%
2002-HK$225.95
2001N/A-100%
2000-HK$180.76-63.64%
1999-HK$497.09

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$52.41-465.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$41.19-386.89%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$5.57-138.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-HK$24.32 69.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$7.79-154.26%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$22.57-257.23%๐Ÿ‡ฌ๐Ÿ‡ง UK
Arrowhead Pharmaceuticals
ARWR
-HK$26.13 81.97%๐Ÿ‡บ๐Ÿ‡ธ USA